Recommendations for the Diagnosis and Treatment of Neuroendocrine Tumors of Gastroenteropancreatic Origin

Authors

  • Juan M O'Connor Clinical oncologist, Head of the Gastrointestinal Tumors Area, Instituto Alexander Fleming. Founding Member ARGENTUM Group. https://orcid.org/0000-0002-6975-5466
  • Enrique Roca Clinical oncologist, Former Head of Oncology Section Hospital B. Udaondo. Founding Member of ARGENTUM Group.

DOI:

https://doi.org/10.52787/agl.v52i2.198

Keywords:

Neuroendocrine tumors, treatment guide, ARGENTUM

Abstract

Neuroendocrine tumors are a relatively rare pathology. They are characterized by being, in general, tumors with indolent biological behavior.1 Thus begin the articles on this entity, we are not original, but it allows us to make some reflections on this island of small tumors.2

References

-1. Mocellin S, Nitti D. Gastrointestinal carcinoid: epidemiological and survival evidence from a large population based study (n = 25 531). (12) Annals of Oncology. 2013:24: 3040-4.

-2. Kvols LK. Revisiting C.G. Moertel´s Land of Small Tumors. 2008;31:5005-7.

- 3. Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Modern Pathology. 2018;31:1770-86.

- 4. Metz DC, Choi J, Strosberg J, et al. A rationale for multidisciplinary care in treating neuroendocrine tumours: Curr. Opin. Endocrinol. Diabetes Obes. 2012;19:306-13.

- 5. O'Connor JM, Belli S, mendez G, Roca E, et al. Somatostatin receptor (SSTR) expression and proliferative index (Ki 67) in 100 patients (pts) with gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Clinical-pathological correlation: Journal of Clinical Oncology. 2005 ASCO Annual Meeting Proceedings.

- 6. Younes R, Garavito G, O'Connor JM, Costa F, Domenichini E, et al. Management of neuroendocrine tumors: A meeting of experts from Latinoamerica. Neuroendocrinology. 2008;88:235-42.

- 7. Oviedo Albor A, Maquieira J, Rizzolo M, Roca E, O'Connor JM, et al. MDT Experience in Argentina in NETs in times of the COVID19 pandemic. s.l.: Abstract, NANETS 2021, Multidisciplinary NET medical virtual Symposium, 2021.

- 8. O’Connor J, Acosta Haab G, Armas I, Belli S, Bruno G, Cabanne A, y cols. Recomendaciones para el diagnóstico y el tratamiento de tumores neuroendocrinos de origen gastroenteropancreáticos. Acta Gastroenterol Latinoam [Internet].2020;50 (s1). https://doi.org/10.52787/MEXR5440

Downloads

Published

2022-06-27

How to Cite

O’Connor, J. M., & Roca, E. (2022). Recommendations for the Diagnosis and Treatment of Neuroendocrine Tumors of Gastroenteropancreatic Origin. Acta Gastroenterológica Latinoamericana, 52(2), 125–127. https://doi.org/10.52787/agl.v52i2.198

Issue

Vol. 52 No. 2 (2022): Acta Gastroenterológica Latinoamericana

Section

Editorials

License

Copyright (c) 2022 Juan Manuel O'Connor, Enrique Roca

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.